BioSpace News Archive

The drive for accuracy, expandability, and convenience in surgical navigation systems is a key factor creating new avenues in the image guided surgery devices market.

The technique fluorescence in situ hybridization is extensively used by cytogeneticists world over for making fluorescent DNA probes with the aim of detecting a range of chromosomal abnormalities in patients.

The global erythropoietin drugs market is prognosticated to demonstrate steady growth in coming years, as reported by Transparency Market Research.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to a new study conducted by Fact.MR, the global byler disease market is expected to develop at a positive rate from 2021 to 2031.

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that the first group of 15 patients have been enrolled and dosed in a Phase 2b viral challenge study (RVL-VRL01) to evaluate the efficacy of intranasal REVTx-99 for the preventive treatment of H3N2 influenza (influenza A) infection in healthy humans.

BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter in a life-saving treatment.

Tachyon Therapeutics, Inc. (“Tachyon” or “the Company”), a private biotechnology company creating novel therapeutics to unlock new pathways to treat advanced cancers, today announced the presentation of data from its TACH101 program in a virtual poster presentation at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium.

Rockwell Medical, Inc. (Nasdaq: RMTI) today announced that its partner in South Korea, Jeil Pharmaceutical Co., Ltd. (“Jeil”), has received a second regulatory approval by the Ministry of Food and Drug Safety of the Republic of Korea for Triferic® Dialysate (ferric pyrophosphate citrate sodium sulfate co-precipitate hydrate) for maintaining hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD).

In its 14th year, Biotech Showcase™, co-produced by Demy-Colton and EBD Group, welcomed over 2,400 attendees, nearly a 10 percent increase from last year, together with over 860 investors, and 320 presenting companies.

Schweiger Dermatology Group, the leading dermatology practice in the Northeast, has announced the acquisition of Theta Dermatology in Altamont, New York.